Drug manufacturers in Ghana, particularly in Accra, Kumasi, are increasingly targeting the US market. With key products such as cocoa, shea butter, cashew nuts, Ghana has significant potential in the American market. However, to legally introduce products into the US, companies must strictly comply with US Food and Drug Administration (FDA) regulations. This article details the FDA requirements related to this topic for Ghana businesses.
Type II DMF content and Letter of Authorization process
FDA regulations in this area apply to all foreign manufacturing facilities that wish to market products in the US. For drug manufacturers in Accra and Kumasi, compliance is not only a legal requirement but also a prerequisite for maintaining business relationships with US import partners. If requirements are not met, shipments can be held at the port, denied entry, or even placed on the FDA import alert list.
Common issues with foreign DMF submissions to the FDA
To export drug to the US, Ghana companies need to: register their facility with the FDA, obtain a DUNS number from Dun & Bradstreet, appoint a US Agent with a US address, and ensure product labels comply with FDA regulations. For products such as cocoa, shea butter, cashew nuts, additional requirements may apply depending on the specific product type. FDABridge helps Ghana companies complete the entire process.
FDABridge supports Ghana exporters
FDABridge specializes in helping drug companies in Ghana complete FDA registration from start to finish. Our services include consulting, DUNS number registration, US Agent provision, FDA facility registration filing, and periodic renewal. Contact us today at fdabridge.com to get started.
هل تحتاج مساعدة في اختيار خدمة؟
قارن الخيارات الرئيسية واختر المسار المناسب لفئة منتجك.